WP_Query Object
(
[query] => Array
(
[post_type] => post
[post_status] => publish
[orderby] => date
[order] => DESC
[ignore_sticky_posts] => 1
[post__not_in] => Array
(
[0] => 379
)
[cat] => 18
[posts_per_page] => 3
)
[query_vars] => Array
(
[post_type] => post
[post_status] => publish
[orderby] => date
[order] => DESC
[ignore_sticky_posts] => 1
[post__not_in] => Array
(
[0] => 379
)
[cat] => 18
[posts_per_page] => 3
[error] =>
[m] =>
[p] => 0
[post_parent] =>
[subpost] =>
[subpost_id] =>
[attachment] =>
[attachment_id] => 0
[name] =>
[pagename] =>
[page_id] => 0
[second] =>
[minute] =>
[hour] =>
[day] => 0
[monthnum] => 0
[year] => 0
[w] => 0
[category_name] => articles
[tag] =>
[tag_id] =>
[author] =>
[author_name] =>
[feed] =>
[tb] =>
[paged] => 0
[meta_key] =>
[meta_value] =>
[preview] =>
[s] =>
[sentence] =>
[title] =>
[fields] =>
[menu_order] =>
=>
[category__in] => Array
(
)
[category__not_in] => Array
(
)
[category__and] => Array
(
)
[post__in] => Array
(
)
[post_name__in] => Array
(
)
[tag__in] => Array
(
)
[tag__not_in] => Array
(
)
[tag__and] => Array
(
)
[tag_slug__in] => Array
(
)
[tag_slug__and] => Array
(
)
[post_parent__in] => Array
(
)
[post_parent__not_in] => Array
(
)
[author__in] => Array
(
)
[author__not_in] => Array
(
)
[search_columns] => Array
(
)
[suppress_filters] =>
[cache_results] => 1
[update_post_term_cache] => 1
[update_menu_item_cache] =>
[lazy_load_term_meta] => 1
[update_post_meta_cache] => 1
[nopaging] =>
[comments_per_page] => 50
[no_found_rows] =>
)
[tax_query] => WP_Tax_Query Object
(
[queries] => Array
(
[0] => Array
(
[taxonomy] => category
[terms] => Array
(
[0] => 18
)
[field] => term_id
[operator] => IN
[include_children] => 1
)
)
[relation] => AND
[table_aliases:protected] => Array
(
[0] => wp_term_relationships
)
[queried_terms] => Array
(
[category] => Array
(
[terms] => Array
(
[0] => 18
)
[field] => term_id
)
)
[primary_table] => wp_posts
[primary_id_column] => ID
)
[meta_query] => WP_Meta_Query Object
(
[queries] => Array
(
)
[relation] =>
[meta_table] =>
[meta_id_column] =>
[primary_table] =>
[primary_id_column] =>
[table_aliases:protected] => Array
(
)
[clauses:protected] => Array
(
)
[has_or_relation:protected] =>
)
[date_query] =>
[request] => SELECT SQL_CALC_FOUND_ROWS wp_posts.ID
FROM wp_posts LEFT JOIN wp_term_relationships ON (wp_posts.ID = wp_term_relationships.object_id)
WHERE 1=1 AND wp_posts.ID NOT IN (379) AND (
wp_term_relationships.term_taxonomy_id IN (18)
) AND wp_posts.post_type = 'post' AND ((wp_posts.post_status = 'publish'))
GROUP BY wp_posts.ID
ORDER BY wp_posts.post_date DESC
LIMIT 0, 3
[posts] => Array
(
[0] => WP_Post Object
(
[ID] => 1566
[post_author] => 1
[post_date] => 2024-07-16 13:52:03
[post_date_gmt] => 2024-07-16 13:52:03
[post_content] =>
Transforming Obesity Treatment with GLP-1s for Older Adults
A recent survey conducted by Gallup reported that perceived effectiveness of weight loss injections are relatively consistent among younger and middle-aged adults, with 70% of those aged 18 to 49 and 67% of those aged 50 to 64 reporting them as effective or extremely effective. Among adults aged 65 and older, however, reported effectiveness is much lower, at 48%.
Older adults often face more health issues or comorbidities, which can make it challenging for them to lose weight and adhere consistently to their treatment plans. Additionally, healthcare providers may encounter greater difficulties in keeping older adults engaged and motivated throughout their weight loss journey.
This age-related disparity points to the need for more tailored treatment plans, closer monitoring of the patient’s day to day health metrics, and additional research to better understand the overall effectiveness of GLP-1 medication to treat obesity in older adults
Mitigating medication risk with remote health tech
One approach to addressing these challenges is the integration of digital care solutions, which can offer greater protection for older patients. By utilizing remote monitoring technologies, healthcare providers can track vital health metrics in real-time, allowing for prompt adjustments to treatment plans as needed. These tools can also facilitate regular communication between patients and providers, ensuring that any concerns or side effects are quickly addressed, thus enhancing the overall effectiveness and safety of the treatment.
With connected health devices that collect patient-generated data on a daily basis, care teams can have more insight into health risks that older patients are more susceptible to when taking GLP-1s:
- Sarcopenia: About a quarter of GLP-1 agonist weight loss results from the loss of muscle and bone, both of which are necessary to protect us as we get older. Although some muscle loss is a natural part of aging, it accelerates while on GLP-1s. Weakened muscles can make everyday activities difficult, and can lead to falls or other injuries. Low muscle mass is also associated with poor health outcomes — researchers found that individuals with diabetes and low muscle mass have a higher risk of mortality from cardiovascular disease.
- Malnutrition: Although suppression of appetite is a key mechanism of GLP-1 medications, too much appetite control can be dangerous, particularly in older adults who are more prone to having reduced food intake. Studies have found diminished appetite is a common problem for older adults — both those living at home and at care facilities. Early insight into a patient’s weight and body composition can help care teams intervene earlier to promote better appetite and food intake. Low muscle mass further compounds the risk of malnutrition. A study led by the Center for Translational Research in Aging & Longevity at Texas A&M University found that current care approaches for malnutrition often don’t account for the importance of muscle mass restoration. Researchers recognized the challenge of measuring body composition in clinical practice, noting “the need to raise awareness of the importance of screening and managing ‘at risk’ patients so it becomes routine is imperative for change to occur.”
- Gastrointestinal side effects: Severe gastrointestinal side effects from these medications can result in dehydration, which may increase the likelihood of falls. The most commonly reported side effects include gastrointestinal issues such as vomiting and nausea. When dehydration occurs, individuals are more prone to dizziness or fainting, raising the risk of falling. For older adults a fall could be the start of serious health issues and can even lead to a long-term disability. It is essential to ensure that older adults taking weight loss medications can monitor their hydration levels on a daily basis.
Daily monitoring of lean mass, water percentage and bones mass
With the Withings Body Pro 2 cellular scale, patients can weigh in each day at home and their body composition information will transmit to their care team automatically. This scale was designed for maximum ease of use, making it ideal for older patients who may not be tech savvy — there's no technical setup required, and patients can use it even if they don’t have a cell phone or internet service.
Daily lean mass, fat mass, water percentage and bone mass metrics provide early insight into which patients are struggling with muscle loss or malnutrition. With this data teams can more quickly identify problems and reach out to those in need. For instance, encouraging patients to increase protein in their diet, drink more water, and do light strength training may help stave off serious health issues.
Motivating and connecting
According to the Pew Research Center, about 27 percent of American seniors live alone. This puts them at higher risk of social isolation, which can affect their well-being and increase their risk of health problems.
Beyond measuring body composition, the Body Pro 2 scale can deliver motivational messages to patients automatically. These messages might offer encouragement to keep walking regularly, take their readings more consistently, remind them of upcoming appointments or congratulate them for reaching a personal health goal.
Prioritizing a personalized approach
Safely prescribing GLP-1 medications for older adults requires a multifaceted approach that combines the integration of connected health devices, closer monitoring of patient body composition, and consistent patient motivation.
These technologies not only enhance the safety and effectiveness of weight loss treatments but also provide motivational support to help older patients stay engaged and connected. By addressing the unique challenges faced by older adults, healthcare providers improve the success of their program.
Disclaimer: The information provided in this article is informational and for content marketing purposes only. It should not be construed as medical advice. The content herein is not intended to replace professional medical consultation, diagnosis, or treatment. We expressly recommend that individuals seek advice from a qualified healthcare professional before considering the use of GLP-1 medications for the treatment of obesity or any other condition.
[post_title] => Safely Prescribing GLP-1 Medications for Older Adults: Remote care solutions that offer protection and connection
[post_excerpt] => Remote care solutions, like connected devices and remote patient monitoring allow for safer GLP-1 use in older adults.
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => safely-prescribing-glp-1-medications-for-older-adults-remote-care-solutions
[to_ping] =>
[pinged] =>
[post_modified] => 2024-07-16 14:16:06
[post_modified_gmt] => 2024-07-16 14:16:06
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://withingshealthsolutions.com/?p=1566
[menu_order] => 0
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[1] => WP_Post Object
(
[ID] => 1331
[post_author] => 1
[post_date] => 2024-06-17 15:43:50
[post_date_gmt] => 2024-06-17 15:43:50
[post_content] =>
When the world’s leading clinicians and researchers gather later this month in Orlando, Florida at ADA’s 84th Scientific Sessions, diabetic peripheral neuropathy and diabetic foot ulcer prevention will be spotlighted. Withings devices have been used in a number of major neuropathy and DFU prevention studies being presented at ADA’s Scientific Sessions as well as other diabetes and neurology conferences this year.
Of note at Scientific Sessions will be the release of findings of the longitudinal study “Combined DPNCheck and SUDOSCAN as a Screening Tool for DPN—The Sheffield Prospective Study.” The results will be shared at 1:15 p.m. EDT in Room W307 immediately following the ADA President’s Select Abstract Presentation. Mohummad Shaan Goonoo of Sheffield Teaching Hospitals and NHS Foundation Trust is scheduled to share the clinical findings.
In addition, Philippe Brunswick, Ph.D. will be presenting a poster at Scientific Sessions on Saturday, June 22 at 12:30 pm in Poster Hall West A4-B2 entitled “Improving Diabetic Foot Ulcer Management with Electrochemical Skin Conductance [Board No. 1803].” Attendees are invited to join Philippe and discuss the results and implications in a small-group setting.
Finally, Withings will be hosting a breakfast for diabetes influencers at 7:00 am EDT on Saturday, June 22 at the Hyatt Regency Orlando hotel next door to the convention center. Participants will be able to dig deeper on the breaking research that will have been presented as well as to experience the Body Pro 2 smart scale for the first time. If you are interested in attending the breakfast, please find more information here.
Interested in partnering with us?
Contact Us
[post_title] => Neuropathy and DFU Prevention to be Highlighted at the ADA’s 84th Scientific Sessions
[post_excerpt] => When the world’s leading clinicians and researchers gather later this month in Orlando, Florida at ADA’s 84th Scientific Sessions, diabetic peripheral neuropathy and diabetic foot ulcer prevention will be spotlighted.
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => neuropathy-and-dfu-prevention-american-diabetes-association
[to_ping] =>
[pinged] =>
[post_modified] => 2024-06-27 09:52:45
[post_modified_gmt] => 2024-06-27 09:52:45
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://withingshealthsolutions.com/?p=1331
[menu_order] => 0
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[2] => WP_Post Object
(
[ID] => 1323
[post_author] => 8
[post_date] => 2024-06-17 15:10:01
[post_date_gmt] => 2024-06-17 15:10:01
[post_content] =>
Withings remote patient monitoring devices will be used by The Strelitz Diabetes Center at Eastern Virginia Medical School (EVMS) in a multi-year ADA-funded study to investigate the efficacy of a culturally-sensitive nutrition program to prevent Type 2 diabetes in African Americans. We interviewed Dr. Henri Parson (EVMS) who is leading the clinical trial, and her co-investigator Ann-Marie Stephens, co-founder of WelFore Health, who is developing the nutritional program and accompanying app, to learn more.
It is well established that the African American population is disproportionately affected by diabetes. The Office of Minority Health at the US Department of Health and Human Services reports that African Americans are:
- 60% more likely to be diagnosed with diabetes (1)
- 2.5 times more likely to be hospitalized with long-term diabetes (2) complications.
- Twice as likely to die from diabetes as Non-Hispanic Whites (3)
The EVMS study will follow 160-180 African American adults who are pre-diabetic or at risk of developing diabetes over the course of 48 weeks. Participants will be brought into the center for quarterly in-person assessments, but they will also be provided Body Pro 2 smart scales and BPM Connect Pro blood pressure monitors for at home use because as Dr. Parson explains, “In a prospective study, we want to capture all the secondary measures we can and have regular remote monitoring.”
The researchers note that there is a gap in the research when it comes to nutrition education. To address this, the nutrition program will emphasize a “food as medicine” approach and will focus on building empathy, trust, and engagement with participants who often have a distrust of clinical trials. Interventions will include meal plans, cooking lessons, daily nudges, and meetings with nutritionists. It will highlight easy-to-follow advice such as making sure non-starchy vegetables make up half the plate and leveraging the power of portion control.
Because Type 2 diabetes tends to follow an intergenerational cycle, WelFore’s Ann-Marie Stephens explains, “We need to help people learn healthier ways to enjoy their cultural heritage foods so they don’t accept the inevitability of diabetes. That to me is the total end game. You’ve got to break that mental mindset.” Heritage foods are such a binding force in the community so preserving culinary traditions is essential to ensure adherence to the program.
When asked for her key takeaway Dr. Parson says, “Healthcare should not be just what the clinical practice guidelines say. It is much much more complex than that. Treat the person as a whole rather than as a symptom. As my mentor Dr. Aaron Vinik often said, “When you understand diabetes, you understand all of health.”
- CDC 2022. National Diabetes Statistics Report, 2021. Appendix Table 3.
- National Healthcare Quality and Disparities Reports. Data Query.
- CDC 2022. National Vital Statistics Report, Vol. 70, No. 7. Table 10.
Interested in partnering with us?
Contact Us
[post_title] => Culturally-Sensitive Nutrition Education Studied for Pre-Diabetic African American Patients
[post_excerpt] => Withings remote patient monitoring devices will be used by The Strelitz Diabetes Center at Eastern Virginia Medical School (EVMS) and WelFore Health for a multi-year, ADA-funded study. In an interview with Dr. Henri Parson (EVMS) and Ann-Marie Stephens (WelFore), Dr. Parsons states, “If we are able to prevent (diabetes) in a population where it is very prevalent, with the idea of using food as medicine, then it is a huge outcome."
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => culturally-sensitive-nutrition-education-studied-for-pre-diabetic-african-american-patients
[to_ping] =>
[pinged] =>
[post_modified] => 2024-06-17 18:42:46
[post_modified_gmt] => 2024-06-17 18:42:46
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://withingshealthsolutions.com/?p=1323
[menu_order] => 0
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
)
[post_count] => 3
[current_post] => -1
[before_loop] => 1
[in_the_loop] =>
[post] => WP_Post Object
(
[ID] => 1566
[post_author] => 1
[post_date] => 2024-07-16 13:52:03
[post_date_gmt] => 2024-07-16 13:52:03
[post_content] =>
Transforming Obesity Treatment with GLP-1s for Older Adults
A recent survey conducted by Gallup reported that perceived effectiveness of weight loss injections are relatively consistent among younger and middle-aged adults, with 70% of those aged 18 to 49 and 67% of those aged 50 to 64 reporting them as effective or extremely effective. Among adults aged 65 and older, however, reported effectiveness is much lower, at 48%.
Older adults often face more health issues or comorbidities, which can make it challenging for them to lose weight and adhere consistently to their treatment plans. Additionally, healthcare providers may encounter greater difficulties in keeping older adults engaged and motivated throughout their weight loss journey.
This age-related disparity points to the need for more tailored treatment plans, closer monitoring of the patient’s day to day health metrics, and additional research to better understand the overall effectiveness of GLP-1 medication to treat obesity in older adults
Mitigating medication risk with remote health tech
One approach to addressing these challenges is the integration of digital care solutions, which can offer greater protection for older patients. By utilizing remote monitoring technologies, healthcare providers can track vital health metrics in real-time, allowing for prompt adjustments to treatment plans as needed. These tools can also facilitate regular communication between patients and providers, ensuring that any concerns or side effects are quickly addressed, thus enhancing the overall effectiveness and safety of the treatment.
With connected health devices that collect patient-generated data on a daily basis, care teams can have more insight into health risks that older patients are more susceptible to when taking GLP-1s:
- Sarcopenia: About a quarter of GLP-1 agonist weight loss results from the loss of muscle and bone, both of which are necessary to protect us as we get older. Although some muscle loss is a natural part of aging, it accelerates while on GLP-1s. Weakened muscles can make everyday activities difficult, and can lead to falls or other injuries. Low muscle mass is also associated with poor health outcomes — researchers found that individuals with diabetes and low muscle mass have a higher risk of mortality from cardiovascular disease.
- Malnutrition: Although suppression of appetite is a key mechanism of GLP-1 medications, too much appetite control can be dangerous, particularly in older adults who are more prone to having reduced food intake. Studies have found diminished appetite is a common problem for older adults — both those living at home and at care facilities. Early insight into a patient’s weight and body composition can help care teams intervene earlier to promote better appetite and food intake. Low muscle mass further compounds the risk of malnutrition. A study led by the Center for Translational Research in Aging & Longevity at Texas A&M University found that current care approaches for malnutrition often don’t account for the importance of muscle mass restoration. Researchers recognized the challenge of measuring body composition in clinical practice, noting “the need to raise awareness of the importance of screening and managing ‘at risk’ patients so it becomes routine is imperative for change to occur.”
- Gastrointestinal side effects: Severe gastrointestinal side effects from these medications can result in dehydration, which may increase the likelihood of falls. The most commonly reported side effects include gastrointestinal issues such as vomiting and nausea. When dehydration occurs, individuals are more prone to dizziness or fainting, raising the risk of falling. For older adults a fall could be the start of serious health issues and can even lead to a long-term disability. It is essential to ensure that older adults taking weight loss medications can monitor their hydration levels on a daily basis.
Daily monitoring of lean mass, water percentage and bones mass
With the Withings Body Pro 2 cellular scale, patients can weigh in each day at home and their body composition information will transmit to their care team automatically. This scale was designed for maximum ease of use, making it ideal for older patients who may not be tech savvy — there's no technical setup required, and patients can use it even if they don’t have a cell phone or internet service.
Daily lean mass, fat mass, water percentage and bone mass metrics provide early insight into which patients are struggling with muscle loss or malnutrition. With this data teams can more quickly identify problems and reach out to those in need. For instance, encouraging patients to increase protein in their diet, drink more water, and do light strength training may help stave off serious health issues.
Motivating and connecting
According to the Pew Research Center, about 27 percent of American seniors live alone. This puts them at higher risk of social isolation, which can affect their well-being and increase their risk of health problems.
Beyond measuring body composition, the Body Pro 2 scale can deliver motivational messages to patients automatically. These messages might offer encouragement to keep walking regularly, take their readings more consistently, remind them of upcoming appointments or congratulate them for reaching a personal health goal.
Prioritizing a personalized approach
Safely prescribing GLP-1 medications for older adults requires a multifaceted approach that combines the integration of connected health devices, closer monitoring of patient body composition, and consistent patient motivation.
These technologies not only enhance the safety and effectiveness of weight loss treatments but also provide motivational support to help older patients stay engaged and connected. By addressing the unique challenges faced by older adults, healthcare providers improve the success of their program.
Disclaimer: The information provided in this article is informational and for content marketing purposes only. It should not be construed as medical advice. The content herein is not intended to replace professional medical consultation, diagnosis, or treatment. We expressly recommend that individuals seek advice from a qualified healthcare professional before considering the use of GLP-1 medications for the treatment of obesity or any other condition.
[post_title] => Safely Prescribing GLP-1 Medications for Older Adults: Remote care solutions that offer protection and connection
[post_excerpt] => Remote care solutions, like connected devices and remote patient monitoring allow for safer GLP-1 use in older adults.
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => safely-prescribing-glp-1-medications-for-older-adults-remote-care-solutions
[to_ping] =>
[pinged] =>
[post_modified] => 2024-07-16 14:16:06
[post_modified_gmt] => 2024-07-16 14:16:06
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://withingshealthsolutions.com/?p=1566
[menu_order] => 0
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[comment_count] => 0
[current_comment] => -1
[found_posts] => 26
[max_num_pages] => 9
[max_num_comment_pages] => 0
[is_single] =>
[is_preview] =>
[is_page] =>
[is_archive] => 1
[is_date] =>
[is_year] =>
[is_month] =>
[is_day] =>
[is_time] =>
[is_author] =>
[is_category] => 1
[is_tag] =>
[is_tax] =>
[is_search] =>
[is_feed] =>
[is_comment_feed] =>
[is_trackback] =>
[is_home] =>
[is_privacy_policy] =>
[is_404] =>
[is_embed] =>
[is_paged] =>
[is_admin] =>
[is_attachment] =>
[is_singular] =>
[is_robots] =>
[is_favicon] =>
[is_posts_page] =>
[is_post_type_archive] =>
[query_vars_hash:WP_Query:private] => f1c78d32b4a5ea84695dc67a9274d272
[query_vars_changed:WP_Query:private] =>
[thumbnails_cached] =>
[allow_query_attachment_by_filename:protected] =>
[stopwords:WP_Query:private] =>
[compat_fields:WP_Query:private] => Array
(
[0] => query_vars_hash
[1] => query_vars_changed
)
[compat_methods:WP_Query:private] => Array
(
[0] => init_query_flags
[1] => parse_tax_query
)
)